| Authors: |
Johns SE; Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA, United States., Keyser-Marcus L; Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA, United States., Abbate A; Pauley Heart Center School of Medicine, Virginia Commonwealth University, Richmond, VA, United States., Boone E; Department of Statistical Sciences and Operations Research, Virginia Commonwealth University, Richmond, VA, United States., Van Tassell B; Pauley Heart Center School of Medicine, Virginia Commonwealth University, Richmond, VA, United States.; Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University, Richmond, VA, United States., Cunningham KA; Department of Pharmacology and Toxicology, Center for Addiction Research, University of Texas Medical Branch, Galveston, TX, United States., Anastasio NC; Department of Pharmacology and Toxicology, Center for Addiction Research, University of Texas Medical Branch, Galveston, TX, United States., Poklis JL; Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, United States., Ramey T; Division of Therapeutics and Medical Consequences, National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, United States., Moeller FG; Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA, United States.; C. Kenneth and Dianne Wright Center for Clinical and Translational Research, Virginia Commonwealth University, Richmond, VA, United States. |
